| 标题 |
[求助补充材料]
Efficacy and safety of eribulin mesylate vs. docetaxel or paclitaxel, combined with trastuzumab and pertuzumab, as first-line treatment for HER2-positive locally advanced or metastatic breast cancer: updated subgroup analyses of JBCRG-M06/EMERALD |
| 网址 | |
| DOI | |
| 其它 |
期刊:Breast cancer research and treatment 作者:Masuda N; Saji S; Kojima Y; Kitada M; Tada H; et al 出版日期:2026/07/08 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)